OSPT is pioneering a unique antibacterial biomaterial technology combining silk and bacteriophages, offering solutions for the growing problem of surgical implant/wound infections, in the largest medical unmet needs.
Founded in January 2020 in Oxford, England, OSPT combines the long-term expertise of clinicians, entrepreneurs and scientists with a common passion to develop superior, natural antibacterial biomaterials which will help people live more actively and longer. OSPT's technology offers a first of a kind, entirely natural and sustainable biomaterial made from bacteriophages and silk fibroin, minimizing the risks of infection and reducing antibiotic use.
Stephanie Lesage - Co-Founder/Director/Chief Executive Officer
Entrepreneur with 10+ years of experience in silk and vascular biomaterials
Mr James Gilbert - Co-Founder/Chief Medical Officer
Vascular Access Lead, Oxford Un. Hospitals, UK and President, VASBI
We are truly excited that OSPT has joined the Bioescalator's thriving environment in July: the access to the state-of-the-art biological facilities at the heart of Oxford's innovative and dynamic community will enable OSPT to propel the development of its first-of-a-kind medical device technology and enable its continuous growth in the next few years.
Stephanie Lesage - Co-founder, CEO, Oxford Silk Phage Technologies Ltd